Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial.

Leslie K, Darvall JN, Chan MTV, Peyton PJ, Myles PS, Corcoran TB, Short TG, Olesnicky BL, Webb AR, Devlin N, Tran-Duy A, Maxwell-Wright H, Schultz-Ferguson C, Fitzpatrick P, Sidiropoulos S, Braat S, Story DA, SNaPP Study Investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network

Open source

DOI: 10.1016/s2213-2600(26)00158-x
Published: 2026 Sep
Container: The Lancet. Respiratory medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00158-x,
  title = {Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial.},
  author = {Leslie K and Darvall JN and Chan MTV and Peyton PJ and Myles PS and Corcoran TB and Short TG and Olesnicky BL and Webb AR and Devlin N and Tran-Duy A and Maxwell-Wright H and Schultz-Ferguson C and Fitzpatrick P and Sidiropoulos S and Braat S and Story DA and SNaPP Study Investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network},
  year = {2026},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(26)00158-x},
  url = {https://doi.org/10.1016/s2213-2600(26)00158-x}
}

RIS

TY  - JOUR
TI  - Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial.
AU  - Leslie K
AU  - Darvall JN
AU  - Chan MTV
AU  - Peyton PJ
AU  - Myles PS
AU  - Corcoran TB
AU  - Short TG
AU  - Olesnicky BL
AU  - Webb AR
AU  - Devlin N
AU  - Tran-Duy A
AU  - Maxwell-Wright H
AU  - Schultz-Ferguson C
AU  - Fitzpatrick P
AU  - Sidiropoulos S
AU  - Braat S
AU  - Story DA
AU  - SNaPP Study Investigators and the Australian and New Zealand College of Anaesthetists Clinical Trials Network
PY  - 2026
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(26)00158-x
UR  - https://doi.org/10.1016/s2213-2600(26)00158-x
ER  -

APA

K, L., JN, D., MTV, C., PJ, P., PS, M., TB, C., TG, S., BL, O., AR, W., N, D., A, T., H, M., C, S., P, F., S, S., S, B., DA, S., & Network, S. S. I. A. T. A. A. N. Z. C. O. A. C. T. (2026). Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(26)00158-x

Source records

pubmed · retrieved 2026-09-26T08:25:19.084Z